Bioventus
BVS
BVS
85 hedge funds and large institutions have $81.8M invested in Bioventus in 2022 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 22 increasing their positions, 28 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
25% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 32
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
67% less capital invested
Capital invested by funds: $246M → $81.8M (-$164M)
Holders
85
Holding in Top 10
2
Calls
$12K
Puts
$12K
Top Buyers
| 1 | +$7.28M | |
| 2 | +$3.17M | |
| 3 | +$1.95M | |
| 4 |
JFG
Jefferies Financial Group
New York
|
+$1.47M |
| 5 |
Millennium Management
New York
|
+$445K |
Top Sellers
| 1 | -$6.04M | |
| 2 | -$5.25M | |
| 3 | -$4.84M | |
| 4 |
EARNEST Partners
Atlanta,
Georgia
|
-$4.33M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$3.73M |